Magnetic resonance imaging for assessment of parametrial tumour spread and regression patterns in adaptive cervix cancer radiotherapy

Acta Oncologica

Volumn 52, Issue 7, 2013, Pages 1384-1390

  Schmid, Maximilian P ^a   Fidarova, Elena ^a   Pötter, Richard ^a   Petric, Primoz ^b   Bauer, Veronika ^a   Woehs, Veronika ^a   Georg, Petra ^a   Kirchheiner, Kathrin ^a   Berger, Daniel ^a   Kirisits, Christian ^a   Dörr, Wolfgang ^a   Dimopoulos, Johannes C A ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INSTITUTE OF ONCOLOGY   (Slovenia)

^c METROPOLITAN HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ARTICLE; BRACHYTHERAPY; CANCER INFILTRATION; CANCER RADIOTHERAPY; CANCER REGRESSION; CHEMORADIOTHERAPY; CHI SQUARE TEST; DIAGNOSTIC VALUE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MORPHOLOGICAL ADAPTATION; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT RESPONSE; UTERINE CERVIX CANCER; CANCER PATIENT; HISTOLOGY; IMAGE GUIDED RADIOTHERAPY; METASTASIS; MINIMAL RESIDUAL DISEASE; MORPHOLOGY; MULTIMODALITY CANCER THERAPY; PARAMETRIAL TUMOR INFILTRATION; TREATMENT OUTCOME; TUMOR REGRESSION; UTERINE CERVIX CARCINOMA;

BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, IMAGE-GUIDED; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN; UTERINE CERVICAL NEOPLASMS;

EID: 84884547389     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2013.818251     Document Type: Article

References (23)

1. Boss EA, Barentsz JO, Massuger LFAG, Boonstra H. The role of MR imaging in invasive cervical carcinoma. Eur Radiol 2000;10:256-70
2. Dimopoulos JCA, Petrow P, Tanderup K, Petric P, Berger D, Kirisits C, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol 2012;103:113-22
3. Dimopoulos J CA, Schard G, Berger D, Lang S, Goldner G, Helbich T, et al. Systematic evaluation of MRI fi ndings in different stages of treatment of cervical cancer: PotentiaLof MRI on delineation of target, pathoanatomic structures, and organs at risk. Int J Radiat Oncol Biol Phys 2006;64:1380-8
4. Nicolet V, Carignan L, Bourdon F, Prosmanne O. M R imaging of cervical carcinoma: A practical staging approach. RadioGraphics 2000;20:1539-49
5. Mayr N A, Tali E T, Yuh W T, Brown B P, Wen B C, Buller RE, et al. Cervical cancer: Application of MR imaging in radiation therapy. Radiology 1993;189:601-8
6. Schmid M P, Mansmann B, Federico M, Dimopoulos J C, Georg P, Fidarova E, et al. Residual tumour volumes and grey zones after external beam radiotherapy (with or without chemotherapy) in cervical cancer patients. Alow fi eld MRI study. Strahlenther Onkol 2013;189:238-44
7. Mayr N A, Taoka T, Yuh W T, Denning L M, Zhen W K, Paulino AC, et al. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2002;52:14-22
8. Wang JZ, Mayr NA, Zhang D, Li K, Grecula JC, Montebello JF, et al. Sequential magnetic resonance imaging of cervical cancer: The predictive value of absolute tumor volume and regression ratio measured before, during, and after radiation therapy. Cancer 2010;116:5093-101
9. Hsu HC, Leung S W, Huang E Y, Wang C J, Sun L M, Fang FM, et al. Impact of the extent of parametriaLinvolvement in patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1998;40:405-10
10. Kim Y B, Lee IJ, Kim SY, Kim JW, Yoon HI, Kim SW, et al. Tumor heterogeneity of FIGO stage III carcinoma of the uterine cervix. Int Radiat Oncol Biol Phys 2009;75:1323-8
11. Pötter R, Georg P, Dimopulos J C, Grimm M, Berger D, Nesvacil N, et al. ClinicaLoutcome of protocol baseDimage (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011;100:116-23
12. Pötter R, Dimopoulos J, Georg P, Lang S, Waldhä u sl C, Wachter-Gerstner N, et al. ClinicaLimpact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007;83:148-55
13. E bner F, Tamussino K, Kressek HY. M agnetic resonance imaging in cervical carcinoma: Diagnosis, staging, and follow-up. Magn Reson Q 1994;10:22-42
14. Chao KS, Williamson JF, Grigsby PW, Perez CA. Uterosacral space involvement in locally advanced carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1998;40:397-403
15. Kundrat R. Ü ber die Ausbreitung des Karzinoms im parametraneNgewebe beim Krebs des Collum uteri. Arch Gynäkol 1903;69:355-409
16. Ebner F, Tamussino K, Kressek HY. M agnetic resonance imaging in cervical carcinoma: Diagnosis, staging, and follow-up. Magn Reson Q 1994;10:22-42
17. Brunet G. E rgebnisse der abdominellen Radikaloperation des Gebärmutterscheidenkrebses mittels Laparotomia hypogastrica. Z Geburtshilfe Gynäkol 1905;56:1-87
18. Ober K G, Huhn F O. Die Ausbreitung des Cervixkrebses auf die Parametrien und diElymphknoten der Beckenwand. Arch Gynäkol 1962;197:262-90
19. Mayr NA, Yuh WTC, Taoka T, Wang JZ, Wu DH, Montebello JF, et al. Serial therapy-induced changes in tumor shape in cervical cancer and their impact on assessing tumor volume and treatment response. AJR Am J Roentgenol 2006;187:65-72
20. Haie-Meder C, Pötter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3Dimage based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005;74:235-45
21. Hö c kel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509-15
22. S chmid M P, Kirisits C, Nesvacil N, Dimopoulos JC, Berger D, P ö tter R. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: A comparison of spatial dose distribution within a matched pair analysis. Radiother Oncol 2011;100:468-72
23. Pötter R, Kirisits C, Fidarova EF, Dimopoulos JC, Berger D, Tanderup K, et al. Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma. Acta Oncol 2008;47:1325-36